You are here

Engine Biosciences to raise additional funding next year

BT_20180521_JQENGINE_3443367.jpg
The process of discovering and developing a drug traditionally costs close to US$2 billion on average, and over 10 years of R&D, says Engine Biosciences CEO Jeffrey Lu.

Singapore

A BIOTECH startup that only this year raised what is believed to be the largest round of seed funding in South-east Asia has plans to raise additional funding as early as next year, The Business Times has learnt.

Engine Biosciences, a Singapore-based company that has

sentifi.com

Market voices on: